About Us

Intuitive Quantitation is an innovative biomedical data analytics company that specializes in producing custom data solutions for clients in the drug discovery and scientific communities.

Access to key data is the lifeblood of scientific discovery. Large data analytics companies stand as would-be gatekeepers to necessary, often pivotal information and then artificially balloon the cost of their services. Companies pay these inflated prices because, until now, they have only had a very small selection of expensive options. I started Intuitive Quantitation to change that; to make these insights more accessible by encouraging innovation across industries and at every stage of drug development. Simply put, we deliver better data in less time for less money than any other option.”

— Todd Verdoorn, Chief Scientist

Our experts use novel data mining and analysis to synthesize vast amounts of information, producing interactive and customized reports that deliver better outcomes. We work closely with clients to provide tailored solutions on even the most challenging of timelines with pricing that is unrivaled in the field.

Chief Scientist

Todd Verdoorn

Dr. Todd Verdoorn, the founder of Intuitive Quantitation, brings over 25 years of extensive experience in drug development and data analysis to the Company. His expertise spans from early drug discovery to late-stage clinical development programs, working with companies of all sizes. Notably, Todd led neurology drug discovery at Bristol Myers Squibb. Additionally, he has served as the Chief Scientific Officer for a software-based diagnostic company, conducted scientific due diligence for prominent investment firms, and contributed to a NASDAQ IPO as Chief Scientific Officer. Todd’s specific expertise lies in advancing pipeline products from preclinical development to initial human trials, including Phase 2 proof-of-concept studies.
As a data-driven scientist, Todd understands the importance of rigorous thinking and meticulous documentation. His work at Intuitive Quantitation centers on extracting knowledge from vast public data sets and distilling it into the most crucial themes and directions.
Todd is an accomplished author and inventor, with numerous publications and multiple patents and patent applications to his name. He conducted post-doctoral research with 1991 Nobel Prize laureate, Bert Sakmann, and served as an Associate Professor of Pharmacology at Vanderbilt University School of Medicine. Todd earned his Ph.D. in Neurobiology from the University of North Carolina.
Todd’s extensive experience and exceptional skill set make him an invaluable asset to Intuitive Quantitation and a respected leader in the industry.

Senior Data Scientist

Benjamin Verdoorn

Benjamin Verdoorn is a highly skilled researcher, data scientist, and computer programmer with extensive experience in the biomedical industry. He holds a degree in Chemistry from St. Olaf College, and worked for several years as a research scientist at Leutonix, Inc and Ecolab, Inc. Benjamin’s passion for data analytics and computer programming eventually led him to specialize in the field of data science.
Benjamin has expertise in multiple programming languages including Python and Igor Pro and is particularly skilled in data visualization and modeling. He is detail-oriented and excels at problem-solving, with a proven track record of taking on complex projects while delivering high-quality results quickly and efficiently.
In addition to his technical skills Benjamin brings a deep understanding of both the challenges and opportunities in the biomedical industry. He enjoys the experience of helping clients better reach their goals by extracting hidden insights and value from large data sets. Benjamin’s energy and precision fuel IQuant’s ability to improve outcomes and advance medical research for clients in this exciting and dynamic field.